10894
K. Ishii et al. / Tetrahedron 60 (2004) 10887–10898
(100), 65 (11); HRMS calcd for C16H18N2O2: 270.1368.
Found: 270.1371.
JZ9.5 Hz, 2-H), 5.34 (dd, 1H, JZ11.0, 0.9 Hz, H-20), 6.45
(dd, 1H, JZ11.0, 10 Hz, H-10), 7.22–7.31 (m, 5H, Ph); 13C
NMR (LA): d 27.0 (t, C-4), 28.1 (q, CMe3), 48.5 (d, C-3),
52.4 (t, C-5), 57.7 (t, 1-CH2Ph), 65.2 (d, C-2), 81.1 (s,
CMe3), 100.7 (d, C-20), 115.5 (s, CN), 127.2, 128.3, 128.7
(3d, 5C in Ph), 138.4 (s, C in Ph), 153.7 (d, C-10), 171.2 (s,
CO2); EI-MS m/z 312 (MC, 11%), 255 (21), 239 (17), 221
(19), 211 (11), 184 (9), 165 (37), 133 (14), 91 (100), 41 (9);
HRMS calcd for C19H24N2O2: 312.1838. Found: 312.1834.
4.4.6. Methyl (2RS,3SR)-1-benzyl-2-[(E)-2-cyanovinyl]-
pyrrolidine-3-carboxylate (E)-11b. An oil; IR (CHCl3):
2210 (C^N), 1725 cmK1 (C]O); 1H NMR (AL4): d 2.01–
2.14 (m, 2H, H2-4), 2.34–2.42 (m with q character, 1H, JZ
9 Hz, H-5), 2.81 (ddd, 1H, JZ9.9, 7.7, 5.5 Hz, H-3), 2.98–
3.03 (m with ddd character, 1H, JZ9.5, 7.3, 2.9 Hz, H-5),
3.30, 3.85 (each d, 2H, JZ12.8 Hz, 1-CH2Ph), 3.34–3.39 (m
with t character, 1H, JZ7 Hz, 2-H), 3.72 (s, 3H, OCH3),
5.69 (dd, 1H, JZ16.3, 1.1 Hz, H-20), 6.70 (dd, 1H, JZ16.3,
7.2 Hz, H-10), 7.24–7.35 (m, 5H, Ph); 13C NMR (AL4): d
27.2 (t, C-4), 49.2 (d, C-3), 52.2 (q, OCH3), 52.7 (t, C-5),
58.5 (t, 1-CH2Ph), 68.6 (d, C-2), 101.3 (d, C-20), 116.9 (s,
CN), 127.2, 128.3, 128.5 (3d, 5C in Ph), 138.1 (s, C in Ph),
155.0 (d, C-10), 173.5 (s, CO2); EI-MS m/z 270 (MC, 17%),
230 (27), 211 (26), 179 (75), 91 (100), 65 (11); HRMS calcd
for C16H18N2O2: 270.1368. Found: 270.1364.
4.4.10. tert-Butyl (2RS,3SR)-1-benzyl-2-[(Z)-2-cyano-
vinyl]pyrrolidine-3-carboxylate 12b. Colorless needles;
mp 78–79 8C (hexane/ethyl acetate); IR (CHCl3): 2230
(C^N), 1725 cmK1 (C]O); 1H NMR (LA): d 1.48 (s, 9H,
CMe3), 1.99–2.08, 2.12–2.18 (each m, 2H, H2-4), 2.37–2.43
(m with q character, 1H, JZ9 Hz, H-5), 2.74 (ddd, 1H, JZ
10.3, 8, 5 Hz, H-3), 2.97–3.02 (m with ddd character, 1H,
JZ9, 8, 2 Hz, H-5), 3.38, 3.82 (each d, 2H, JZ13.1 Hz,
1-CH2Ph), 3.57–3.61 (m with dd character, 1H, JZ9, 8 Hz,
H-2), 5.40 (dd, 1H, JZ11.0, 0.6 Hz, H-20), 6.37 (dd, 1H,
JZ11.0, 9.5 Hz, H-10), 7.21–7.31 (m, 5H, Ph); 13C NMR
(LA): d 26.6 (t, C-4), 27.9 (q, CMe3), 50.2 (d, C-3), 53.2 (t,
C-5), 58.3 (t, 1-CH2Ph), 68.3 (d, C-2), 81.4 (s, CMe3), 101.6
(d, C-20), 115.6 (s, CN), 127.2, 128.2, 128.7 (3d, 5C in Ph),
138.5 (s, C in Ph), 154.9 (d, C-10), 172.0 (s, CO2); EI-MS
m/z 312 (MC, 4%), 255 (39), 239 (15), 216 (10), 165 (48),
91 (100), 41 (6). Anal. Calcd for C19H24N2O2: C, 73.05; H,
7.74; N, 8.97%. Found: C, 73.14; H, 7.81; N, 8.92%.
4.4.7. Methyl (2RS,3RS)-1-benzyl-2-[(Z)-2-cyanovinyl]-
pyrrolidine-3-carboxylate (Z)-11a. An oil; bp 160 8C at
0.40 mm Hg; IR (CHCl3): 2220 (C^N) and 1730 cmK1
1
(C]O); H NMR (AL4): d 2.01–2.09, 2.23–2.89 (each m,
2H, H2-4), 2.45 (dt, 1H, JZ9.5, 7.0 Hz, H-5), 3.04–3.09 (m,
1H, H-5), 3.29–3.37 (m with q character, 1H, JZ9 Hz, H-3),
3.54, 3.76 (each d, 2H, JZ13.2 Hz, 1-CH2Ph), 3.66 (s, 3H,
OCH3), 3.86–3.91 (m with dd character, 1H, JZ9.5, 9.2 Hz,
H-2), 5.35 (dd, 1H, JZ11.0, 0.7 Hz, H-20), 6.42 (dd, 1H,
JZ11.0, 9.5 Hz, H-10), 7.29–7.31 (5H, m, Ph); 13C NMR
(AL3): d 27.1 (t, C-4), 47.7 (d, C-3), 51.8 (q, OCH3), 52.4 (t,
C-5), 57.7 (t, 1-CH2Ph), 65.2 (d, C-2), 101.0 (d, C-20), 115.3
(s, CN), 127.2, 128.2, 128.7 (3d, 5C in Ph), 138.1 (s, C in
Ph), 153.3 (d, C-10), 172.6 (s, CO2); EI-MS m/z 270 (MC,
33%), 230 (16), 211 (24), 184 (15), 179 (62), 91 (100), 65
(8). Anal. Calcd for C16H18N2O2: C, 71.09; H, 6.71; N,
10.36%. Found: C, 70.94; H, 6.70; N, 10.30%.
4.4.11. (2Z,10RS,20RS,50SR)-3-(3-Benzyl-8-oxo-3-azabi-
cyclo[3.3.0]oct-2-yl)acrylonitrile 13. Colorless crystals;
mp 91–92 8C (hexane/ethyl acetate); IR (CHCl3): 2220
(C^N), 1730 cmK1 (C]O); 1H NMR (AL4): d 1.80–1.89,
2.03–2.14 (each m, 2H, H2-60), 2.21–2.30 (m with dddd
character, 1H, JZ18, 8, 5, 1 Hz, H-70), 2.35–2.46 (m, 1H,
H-70), 2.54 (dd, 1H, JZ9.8, 8 Hz, H-40), 2.78–2.83 (m with t
character, 1H, JZ8 Hz, H-10), 2.89 (dd, 1H, JZ9.8, 1.4 Hz,
H-40), 2.900–2.98 (m, 1H, H-50), 3.17, 3.79 (each d, 2H, JZ
13.8 Hz, 3 -CH2Ph), 3.68 (dd, 1H, JZ9.8, 7.3 Hz, H-20),
5.51 (dd, 1H, JZ11.0, 0.7 Hz, H-2), 6.46 (dd, 1H, JZ11.0,
9.8 Hz, H-30), 7.22–7.32 (50H, m, Ph); 13C NMR (AL3):0 d
28.3 (t, C-6 ), 38.0 (d, C-5 ), 39.4 (t, C-70), 55.2 (d, C-1 ),
57.9, 61.0 (2t, C-40, 1-CH2Ph), 68.3 (d, C-20), 102.1 (d,
C-2), 115.3 (s, C-1), 127.0, 128.1, 128.2 (3d, 5C in Ph),
138.2 (s, C in Ph), 153.0 (d, C-3), 217.9 (s, C-80); EI-MS m/z
266 (MC, 33%), 226 (5), 210 (20), 184 (13), 175 (16), 91
(100), 65 (9). Anal. Calcd for C17H18N2O: C, 76.66; H,
6.81; N, 10.52%. Found: C, 76.71; H, 6.86; N, 10.46%.
4.4.8. Methyl (2RS,3SR)-1-benzyl-2-[(Z)-2-cyanovinyl]-
pyrrolidine-3-carboxylate (Z)-11b. Colorless crystals; mp
45–48 8C; IR (CHCl3): 2220 (C^N), 1730 cmK1 (C]O);
1H NMR (AL4): d 2.05–2.23 (m, 2H, H2-4), 2.37–2.45 (m,
1H, H-5), 2.83 (ddd, 1H, JZ10.6, 8.4, 5.5 Hz, H-3), 3.00–
3.05 (m with ddd character, 1H, JZ9.5, 8.1, 2 Hz, H-5),
3.40, 3.80 (each d, 2H, JZ13.2 Hz, 1-CH2Ph), 3.61–3.67 (m
with t character, 1H, JZ9 Hz, H-2), 3.75 (s, 3H, OCH3),
5.42 (dd, 1H, JZ11.0, 0.7 Hz, H-20), 6.38 (dd, 1H, JZ11.0,
9.2 Hz, H-10), 7.25–7.32 (m, 5H, Ph); 13C NMR (AL4): d
26.8 (t, C-4), 49.0 (d, C-3), 52.3 (q, OCH3), 53.1 (t, C-5),
58.4 (t, 1-CH2Ph), 68.3 (d, C-2), 101.8 (d, C-20), 115.2 (s,
CN), 127.1, 128.1, 128.6 (3d, 5C in Ph), 138.2 (s, C in Ph),
154.3 (d, C-10), 173.0 (s, CO2); EI-MS m/z 270 (MC, 23%),
230 (34), 211 (29), 179 (100), 91 (82), 65 (9); HRMS calcd
for C16H28N2O2: 270.1368. Found: 270.1367.
4.4.12. (2Z,10RS,20RS,50SR)-3-(3-Benzyl-6,8-dioxo-7-
phenyl-3,7-diazabicyclo[3.3.0]oct-2-yl)acrylonitrile 14.
Colorless crystals; mp 49–51 8C; IR (CHCl3): 2230
1
(C^N), 1720 cmK1 (C]O); H NMR (LA): d 2.56 (dd,
1H, JZ10.1, 7.9 Hz, H-40), 3.33, 3.83 (each d, 2H, JZ
13.4 Hz, 30-CH2Ph), 3.36 (td, 1H, JZ7.9, 0.6 Hz, H-50),
3.47 (d, 1H, JZ10.1 Hz, H-40), 3.54 0(t, 1H, JZ7.9 Hz,
H-10), 3.79 (dd, 1H, JZ9.8, 7.9 Hz, H-2 ), 5.59 (dd, 1H, JZ
11.0, 0.6 Hz, H-2), 6.45 (dd, 1H, JZ11.0, 9.8 Hz, H-3),
7.20–7.23, 7.24–7.32, 7.39–7.43, 7.47–7.51 (4m, 10H, Ph);
13C0 NMR (LA):0 d 43.4 (d, C-50), 48.8 0(d, C-10), 55.9 (t,
C-4 ), 56.8 (t, 3 -CH2Ph), 66.4 (d, C-2 ), 103.5 (d, C-2),
115.2 (s, C-1), 126.3, 127.6, 128.4, 128.5, 128.8, 129.2 (6d,
10C in Ph), 131.7, 136.8 (2s, 2C in Ph), 151.1 (d, C-3),
4.4.9. tert-Butyl (2RS,3RS)-1-benzyl-2-[(Z)-2-cyanovi-
nyl]pyrrolidine-3-carboxylate 12a. Colorless crystals;
mp 54–55 8C; IR (CHCl3): 2230 (C^N), 1725 cmK1
1
(C]O); H NMR (LA): d 1.42 (s, 9H, CMe3), 1.96–2.03,
2.16–2.26 (each m, 2H, H2-4), 2.46 (dt, 1H, JZ9.2, 7.0 Hz,
H-5), 3.02 (ddd, 1H, JZ9.2, 8, 2 Hz, H-5), 3.18–3.24 (m
with q character, 1H, JZ9 Hz, H-3), 3.55, 3.75 (each d, 2H,
JZ13.4 Hz, 1-CH2Ph), 3.88–3.92 (m with t character, 1H,